Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy
Open Access
Online Resource
Type Journal Article
Year 2022
Language English
Views 27
Downloads 0
Research Methods

Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy

Wendy Prosser , Karan Sagar, Michelle Seidel, Soumya Alva
External / Open Access
2022 BMC Health Services Research DOI: 10.1186/s12913-022-08616-9

Abstract

Abstract Background In 2014, Gavi and partners developed a global Immunization Supply Chain (iSC) Strategy, 2015–2020, which prioritized functioning cold chain equipment (CCE) and additional storage capacity. In 2016, Gavi launched the Cold Chain Equipment Optimization Platform (CCEOP) as a funding mechanism to improve CCE availability. In 2018, Gavi commissioned an evaluation of CCEOP in Guinea, Kenya and Pakistan. The global iSC Strategy has recently been revised, drawing on findings from effective vaccine management assessments and practical experiences. This case study presents the CCEOP evaluation and how its findings reinforced the revision of the iSC strategy. Methods The CCEOP evaluation used a prospective mixed-methods research design in all three countries involving key informant interviews at multiple levels of the health system, document reviews, direct observation (as and when possible), and a health facility assessment. Results Results show that CCEOP was effective at increasing the number of available and reliable CCE, and establishing improved management processes using the project management team (PMT) approach for country management systems and the service bundle provider approach for installation and maintenance. CCEOP also extended the iSC and immunization services in countries. The evaluation results also show gaps in the overall supply chain system, including CCE maintenance. Discussion Gavi has recently revised its iSC strategy, which has addressed gaps identified through assessments and practical experiences from stakeholders. Results of the CCEOP evaluation reinforce many of these findings. The strategy now provides more emphasis on supporting the fundamental infrastructure and establishing strong processes for maintenance. It also emphasizes strategic planning and forward thinking for iSC decisions, building on the processes established for the PMT through CCEOP. The original iSC strategy was an impetus for the establishment of CCEOP. The new strategy reflects shifting trends and priorities to fill gaps identified through practical experience, advocated for by stakeholders and thought leaders engaged in the iSC, and validated by the evaluation. It demonstrates the importance of aligning stakeholders with clear objectives and a sound strategy.
Full Title Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy
Primary Author Wendy Prosser
Co-Authors Karan Sagar, Michelle Seidel, Soumya Alva
Publication Type Journal Article
Year 2022
Journal BMC Health Services Research
Volume / Issue Vol. 22, No. 1
Pages 1–12
Category Research Methods
Institution External / Open Access
Access Open Access
Added to Library March 24, 2026

Cite This Publication

APA
Wendy Prosser, Karan Sagar, Michelle Seidel, Soumya Alva (2022). Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy. *BMC Health Services Research*, 22(1), 1–12.
MLA
Wendy Prosser. "Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy." *BMC Health Services Research*, vol. 22, no. 1, 2022, pp. 1–12.
DOI
https://doi.org/10.1186/s12913-022-08616-9

Keywords & Tags